JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）
Clinical trial NCT06505837 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06505837
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-11
- Primary completion
- 2026-06-30
- Enrollment
- 395
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.